Table 1.

Analysis of long-term expression of human glucose-6-phosphate dehydrogenase after syngeneic bone marrow transplantation with transduced hematopoietic stem cells

Primary BMTSecondary BMT
Mice transplanted, n 26* 26 
Mice expressing hG6PD, n 25  22  
Mice with long-term expression, n (follow-up, mo) 16 (4-20) 14 (6-16)  
Mice with short-term expression, n  9   8  
Provirus1-153/nonexpressing mice1-155 0/10 0/12  
Chimerism1-155%, mean ± SD (range) 40 ± 14 (22-66) ND  
Provirus copy number per donor cell,1-154 mean ± SD (range) 2.8 ± 2.1 (0.9-7.6) ND 
Primary BMTSecondary BMT
Mice transplanted, n 26* 26 
Mice expressing hG6PD, n 25  22  
Mice with long-term expression, n (follow-up, mo) 16 (4-20) 14 (6-16)  
Mice with short-term expression, n  9   8  
Provirus1-153/nonexpressing mice1-155 0/10 0/12  
Chimerism1-155%, mean ± SD (range) 40 ± 14 (22-66) ND  
Provirus copy number per donor cell,1-154 mean ± SD (range) 2.8 ± 2.1 (0.9-7.6) ND 

BMT indicates bone marrow transplantation; hG6PD, human glucose-6-phosphate dehydrogenase; ND, not determined.

*

Mice with donor hematopoiesis.

From 8 primary recipients.

Mice that lost hG6PD expression within 3 to 4 months.

F1-153

Presence of the provirus detected by Southern blotting.

F1-155

Mice that failed or ceased to express hG6PD.

F1-154

See “Materials and methods.”

Close Modal

or Create an Account

Close Modal
Close Modal